Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sponsor of NCT03233854
Tarrytown, New York, United States
- Ownership
- Private
- Employees
- ~13450
- Development stage
- Other
01
Overview
Regeneron Pharmaceuticals is a leading biotechnology company that discovers, develops, and commercializes medicines for serious diseases. The company is renowned for its proprietary VelociSuite technology, which enables the rapid development of fully human monoclonal antibodies. Its commercial portfolio includes blockbuster treatments such as Eylea for retinal diseases, Dupixent for inflammatory conditions, and Libtayo for various cancers. Regeneron maintains a robust pipeline across oncology, immunology, infectious diseases, and rare diseases, often collaborating with major partners like Sanofi and Bayer.
- Therapeutic areas
- CardiovascularDermatologyOphthalmologyPulmonologyOncology
- Modalities
- Monoclonal antibodyBispecific monoclonal antibodyRecombinant fusion proteinSmall moleculesiRNAGene therapy
- Industry
- Pharma
02
Partnerships
Beyond the preview
Go deeper on Sponsor of NCT03233854.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sponsor of NCT03233854.